MIAN, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.552
AS - Asia 6.328
EU - Europa 4.336
AF - Africa 1.634
SA - Sud America 1.426
OC - Oceania 154
Continente sconosciuto - Info sul continente non disponibili 77
Totale 26.507
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.735
SG - Singapore 2.172
CN - Cina 1.461
IT - Italia 944
BR - Brasile 855
HK - Hong Kong 607
VN - Vietnam 497
DE - Germania 385
SE - Svezia 296
FI - Finlandia 284
GB - Regno Unito 222
RU - Federazione Russa 208
NL - Olanda 207
PL - Polonia 202
FR - Francia 172
BJ - Benin 148
KR - Corea 125
AR - Argentina 120
UA - Ucraina 101
IN - India 94
MX - Messico 94
IE - Irlanda 85
CO - Colombia 78
AT - Austria 77
CA - Canada 75
ZA - Sudafrica 75
ID - Indonesia 72
TR - Turchia 70
JP - Giappone 69
BE - Belgio 63
CI - Costa d'Avorio 63
MA - Marocco 59
IQ - Iraq 58
VE - Venezuela 57
AE - Emirati Arabi Uniti 56
EC - Ecuador 56
TN - Tunisia 52
MK - Macedonia 51
PY - Paraguay 51
UY - Uruguay 51
ES - Italia 50
LV - Lettonia 50
AO - Angola 49
CR - Costa Rica 49
GR - Grecia 49
HR - Croazia 49
JM - Giamaica 49
KE - Kenya 49
RO - Romania 49
RS - Serbia 49
AM - Armenia 47
HU - Ungheria 47
SI - Slovenia 47
SN - Senegal 47
BD - Bangladesh 46
CH - Svizzera 46
PK - Pakistan 46
AL - Albania 45
EG - Egitto 45
NZ - Nuova Zelanda 45
SK - Slovacchia (Repubblica Slovacca) 45
CW - ???statistics.table.value.countryCode.CW??? 44
KG - Kirghizistan 44
MY - Malesia 44
NO - Norvegia 44
PA - Panama 44
BG - Bulgaria 43
CZ - Repubblica Ceca 43
DK - Danimarca 43
PE - Perù 43
AZ - Azerbaigian 42
SO - Somalia 42
TH - Thailandia 42
BZ - Belize 41
CY - Cipro 41
GF - Guiana Francese 41
GT - Guatemala 41
KZ - Kazakistan 41
LA - Repubblica Popolare Democratica del Laos 41
PR - Porto Rico 41
BW - Botswana 40
DJ - Gibuti 40
DZ - Algeria 40
IR - Iran 40
JO - Giordania 40
LC - Santa Lucia 40
PH - Filippine 40
SA - Arabia Saudita 40
BA - Bosnia-Erzegovina 39
BO - Bolivia 39
EE - Estonia 39
IL - Israele 39
LU - Lussemburgo 39
MU - Mauritius 39
NE - Niger 39
NI - Nicaragua 39
AD - Andorra 38
AF - Afghanistan, Repubblica islamica di 38
AU - Australia 38
CG - Congo 38
Totale 24.734
Salva come PNG Salva come JPEG
Città #
Fairfield 1.733
Ashburn 1.518
Singapore 1.185
Woodbridge 939
Chandler 733
Houston 706
Seattle 622
Cambridge 615
Ann Arbor 595
Wilmington 569
Hong Kong 556
Beijing 447
Boardman 257
Santa Clara 249
Jacksonville 202
Los Angeles 190
Padova 182
Princeton 182
Hefei 175
San Diego 160
Cotonou 146
Ho Chi Minh City 134
Bytom 121
Medford 113
Des Moines 112
Dong Ket 109
Helsinki 105
Seoul 96
Munich 91
Hanoi 83
New York 80
Nanjing 79
São Paulo 78
Chicago 75
Dublin 73
Buffalo 69
Milan 68
Roxbury 64
Abidjan 62
London 62
Nuremberg 60
Dakar 47
Turku 47
Warsaw 47
Guangzhou 44
Riga 44
Tokyo 44
Luanda 43
Panama City 42
Yerevan 42
Bishkek 40
Montevideo 40
Vienna 40
Columbus 39
Nairobi 39
Redondo Beach 39
San José 39
Amman 38
Baku 38
Managua 38
Castries 37
Vientiane 37
Kampala 36
Niamey 36
Andorra la Vella 35
Kingston 35
Willemstad 35
Djibouti 34
Jinan 34
Johannesburg 34
Kigali 34
Stockholm 34
Bamako 33
Bridgetown 33
Lusaka 33
Ouagadougou 33
Ulan Bator 33
Antananarivo 31
Kinshasa 31
Skopje 31
Brussels 30
Libreville 30
Phnom Penh 30
Reykjavik 30
Rome 30
Shenyang 30
Tashkent 30
Dallas 29
Gaborone 29
Montreal 29
Changsha 28
Conakry 28
Lima 28
Nassau 28
Tirana 28
Zagreb 28
Accra 27
Falls Church 27
Harare 27
Nanchang 27
Totale 15.737
Salva come PNG Salva come JPEG
Nome #
0C22 men2A da mutazione di ret C6009S. descrizione di una grande famiglia 458
L’elastosonografia come sostituto dell’esame citologico nei nodi soffici 401
PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY 316
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. 285
The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes 278
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 277
Overexpression of L-Type amino acid transporter 1 (LAT1) and 2 (LAT2): Novel markers of neuroendocrine tumors 241
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients 233
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 227
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience 221
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 216
Bone turnover markers, BMD and TBS after short-term, high-dose glucocorticoid therapy in patients with Graves’ orbitopathy: a small prospective pilot study 215
Prevalence, Tumorigenic Role, and Biochemical Implications of Rare BRAF Alterations. 208
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 204
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 204
The PDCD4/miR-21 pathway in medullary thyroid carcinoma. 203
Iodine status from childhood to adulthood in females living in North-East Italy: Iodine deficiency is still an issue. 202
Functional Significance of the Novel H-RAS Gene Mutation M72I in a Patient with Medullary Thyroid Cancer. 202
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. 200
Restricted intraindividual urinary iodine concentration variability in nonfasting subjects 198
Association of primary aldosteronism with chronic thyroiditis 196
Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors. 196
Calcitonin measurement and immunoassay interference: A case report and literature review 195
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake 193
Biological effects of EF24, a curcumin derivative, alone or combined with mitotane in adrenocortical tumor cell lines 193
PTH: Redefining Reference Ranges in a Healthy Population-The Role of Interfering Factors and the Type of Laboratory Assay 191
Efficacy of educational intervention to improve awareness of the importance of iodine, use of iodized salt, and dietary iodine intake in northeastern Italian schoolchildren 190
BRAF in primary and recurrent papillary thyroid cancers the relationship with (131) 1 and 2 [(18)F] fluoro-2-deoxy-D-glucose uptake ability. 189
EF24 (a curcumin analog) and ZSTK474 emphasizes the effect of cabozantinib in medullary thyroid cancer 189
The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area 186
Iodine status in schoolchildren living in northeast italy:the importance of iodized-salt use and milk consumption. 184
Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience 183
Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment 183
Normal values for thyroid ultrasonography, goiter prevalence and urinary iodine concentration in schoolchildren of the Veneto Region, Italy 182
Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience. 182
Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: A monocentric case series at a tertiary-level Endocrinology unit 181
Galectin-3 cytotest in thyroid follicular neoplasia: a prospective,monoinstitutional study 177
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario 177
RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series 175
Selenium Supplementation, Body Mass Composition, and Leptin Levels in Patients with Obesity on a Balanced Mildly Hypocaloric Diet: A Pilot Study 175
microRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. 174
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma 173
BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer 171
Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models 169
Impact of multidimensional assessment on anti-fracture treatment decisions in patients with fragility hip fractures within a Fracture Liaison Service 168
A Multiomodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients 168
Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening 168
MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome 167
The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer 167
MEN2A/FMTC AND THE V804M RET MUTATION 166
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. 166
INFLUENCE OF PHYSIOLOGICAL DIETARY SELENIUM SUPPLEMENTATION ON THE NATURAL COURSEOF AUTOIMMUNE THYROIDITIS 165
Comparison Of The Diagnostic Accuracy Of Combined Elastosonography And Braf Analysis Versus Cytology And Ultrasonography For Thyroid Nodule Suspected Of Malignancy. 164
Retinal photoreceptor functions are compromised in patients with resistance to thyroid hormone syndrome (RTHβ) 162
Amiodarone-induced thyrotoxicosis: Differential diagnosis using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR) 162
A Novel Thyroid Hormone Receptor Beta Mutation (G357R) in a Family with Resistance to Thyroid Hormone Beta: Extending the Borders of the "Hot" Region in the THRB Gene 161
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants 160
Milk represents an important source of iodine in schoolchildren of the Veneto region, Italy 158
Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications 156
The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways. 155
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling 155
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings 154
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 153
Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity? 153
Deregulated expression of VHL mRNA variants in papillary thyroid cancer 152
Effects of selenium supplementation on the natural course of autoimmune thyroiditis: A short review. 152
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 151
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 150
Sodium/iodide symporter in thyroid cancer 150
Iodine status in pregnancy: role of dietary habits and geographical origin 150
Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma 150
Familial nonsyndromic pheochromocytoma. 149
Autoimmune thyroiditis incidence in a large population-based study in northeastern Italy 149
Real-world performance of ATA risk estimates in predicting 1-year DTC outcomes: A prospective multicenter study of 2000 patients (ITCO Study #3) 148
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows 148
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer 145
Taking care of inpatients with fragility hip fractures: the hip-padua osteosarcopenia (Hip-POS) fracture liaison service model 144
PDCD4 expression in thyroid neoplasia 144
First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans 144
Effects of Handroanthus impetiginosus (Mart. ex DC.) Mattos extract on inflammatory, immune, atherogenic profile and differentiation in THP-1 cell line 143
Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations 143
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer. 142
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 142
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. 142
The role of the size in thyroid cancer risk stratification 142
Dose giornaliera ottimale di Levotiroxina nel trattamento dell'ipotiroidismo primario 140
Biological activities of the aerial and undergound parts of Gymnadenia nigra Rchb.f. (syn. Nigritella nigra (L.) Rchb. f.) from the Italian Alps 139
TSH-receptor autoantibodies in patients with chronic thyroiditis and hypothyroidism 138
Follicular Thyroid Carcinoma with Metastases to the Pituitary Causing Pituitary Insufficiency. 137
Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT. 137
RET codon 609 mutations: a contribution for better clinical managing 136
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma 136
Differences in autoimmune thyroid diseases between females and males: the result of a complex interconnection of factors 136
Circulating miR-146a predicts glucocorticoid response in thyroid eye disease 135
Insulin autoimmune syndrome: from diagnosis to clinical management 135
Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up? 135
Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas 134
Changing dietary habits in veneto region over two decades: Still a long road to go to reach an iodine-sufficient status 134
Role of Lugol solution before total thyroidectomy for Graves’ disease: randomized clinical trial 132
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells. 132
Totale 17.737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.515
article - articoli 77.654
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 714
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.883
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.478 0 0 0 0 0 147 81 178 257 336 207 272
2021/20222.095 66 223 211 167 166 129 138 218 144 56 172 405
2022/20231.546 314 200 14 204 216 216 17 85 168 23 69 20
2023/20241.106 41 106 158 91 101 106 121 63 61 56 106 96
2024/20254.374 35 242 247 200 499 182 233 370 405 159 710 1.092
2025/202610.664 975 1.746 2.637 3.189 1.751 366 0 0 0 0 0 0
Totale 26.733